AbstractMost human antibodies against HPV16 can be blocked by the monoclonal antibody H16.V5. To investigate whether H16.V5 and human sera recognize similar epitopes, hybrid capsids containing different parts of HPV16 and HPV11 were evaluated for reactivity with human sera. The antibody responses among HPV 16-/HPV11+sera to HPV11 and to hybrid capsids containing the HPV11 C-terminus were strongly correlated. The antibody responses among HPV 16+/HPV11-sera to HPV16 and to a hybrid containing the HPV16 C-terminus were correlated and there was also reactivity with a hybrid containing the H16.V5 epitope in the HPV11 backbone. Several HPV16-/11- children’s sera were reactive with hybrid capsids, implying that a native capsid structure is essenti...
AbstractCryo-electron microscopy (cryo-EM) was used to solve the structures of human papillomavirus ...
Human serum samples derived from a case-control study of patients with cervical carcinoma (n = 174) ...
International audienceThe majority of the neutralizing epitopes of papillomaviruses (PV) are conform...
AbstractWe used human papillomavirus type 16 (HPV-16) particles composed of capsid proteins L1 and L...
Human papillomavirus (HPV) type 16 is the major cause of cervical intraepithelial neoplasia and anog...
AbstractMouse monoclonal antibodies (mAbs) were raised against the major capsid protein, L1, of huma...
We have identified regions of the major capsid protein, L1, of the human papillomavirus (HPV) type 1...
Cancers attributable to human papillomavirus (HPV) place a huge burden on the health of both men and...
Certain types of human papillomavirus (HPV), notably HPV type 16, are associated with flat or invert...
Mouse monoclonal antibodies (mAbs) were raised against the major capsid protein, L1, of human papill...
Human papillomavirus type 16 (HPV-16) is a major cause of human cancer. Effective prophylactic vacci...
Abstract Background Persistent infection of human papillomavirus (HPV) types 16 and 18 causes cervic...
Mice of three haplotypes (H-2, H-2, and H-2) were immunized with synthetic HPV16 virus-like particle...
AbstractA panel of 24 monoclonal antibodies (MAbs) was generated against human papillomavirus (HPV) ...
AbstractHuman papillomavirus (HPV) hybrid virus-like particles (VLPs) were prepared using complement...
AbstractCryo-electron microscopy (cryo-EM) was used to solve the structures of human papillomavirus ...
Human serum samples derived from a case-control study of patients with cervical carcinoma (n = 174) ...
International audienceThe majority of the neutralizing epitopes of papillomaviruses (PV) are conform...
AbstractWe used human papillomavirus type 16 (HPV-16) particles composed of capsid proteins L1 and L...
Human papillomavirus (HPV) type 16 is the major cause of cervical intraepithelial neoplasia and anog...
AbstractMouse monoclonal antibodies (mAbs) were raised against the major capsid protein, L1, of huma...
We have identified regions of the major capsid protein, L1, of the human papillomavirus (HPV) type 1...
Cancers attributable to human papillomavirus (HPV) place a huge burden on the health of both men and...
Certain types of human papillomavirus (HPV), notably HPV type 16, are associated with flat or invert...
Mouse monoclonal antibodies (mAbs) were raised against the major capsid protein, L1, of human papill...
Human papillomavirus type 16 (HPV-16) is a major cause of human cancer. Effective prophylactic vacci...
Abstract Background Persistent infection of human papillomavirus (HPV) types 16 and 18 causes cervic...
Mice of three haplotypes (H-2, H-2, and H-2) were immunized with synthetic HPV16 virus-like particle...
AbstractA panel of 24 monoclonal antibodies (MAbs) was generated against human papillomavirus (HPV) ...
AbstractHuman papillomavirus (HPV) hybrid virus-like particles (VLPs) were prepared using complement...
AbstractCryo-electron microscopy (cryo-EM) was used to solve the structures of human papillomavirus ...
Human serum samples derived from a case-control study of patients with cervical carcinoma (n = 174) ...
International audienceThe majority of the neutralizing epitopes of papillomaviruses (PV) are conform...